Evan David Seigerman, BMO managing director, joins ‘Fast Money’ to discuss Novo sinking on its obesity drug data. Source link
Trending
- The tricky game of evaluating QBs out of the transfer portal: ‘So many things you don’t know’
- Why the ‘great resignation’ became the ‘great stay’: labor economists
- The ‘weight-loss trade’ has stalled. What it will take to revive interest
- Health care looks cheap going into 2025. How to play it with options
- Two years later, a former Jets play-caller gets the last laugh
- Stocks making the biggest moves midday: Nordstrom, Honda, MicroStrategy, Broadcom and more
- Three power stocks have soared on AI demand — the rally may just be starting
- 1 million taxpayers to receive up to $1,400 in ‘special payments’
Money
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via EmailFast MoneyDr. Peter…
The ‘Fast Money’ traders talk Apple hitting a record close and what that means for…
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via EmailDan Morehead, Pantera…
The final trades of the day with CNBC’s Melissa Lee and the Fast Money traders.…
Amy Burroughs, Terns Pharma CEO, joins ‘Closing Bell Overtime’ to talk progress in its GLP-1…
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via EmailFast MoneySteven Wieting,…
